VALSARTAN -MEDO 160 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

VALSARTAN

Mevcut itibaren:

A.L. MEDI-MARKET LTD.

ATC kodu:

C09CA03

Farmasötik formu:

FILM COATED TABLETS

Kompozisyon:

VALSARTAN 160 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

MEDOCHEMIE LTD, CYPRUS

Terapötik alanı:

VALSARTAN

Terapötik endikasyonlar:

For treatment of hypertension. Valsartan-Medo is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan-Medo signicantly reduced hospitalisations for heart failure. There is no evidence that Valsartan-Medo provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan-Medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

Yetkilendirme tarihi:

2021-05-27

Bilgilendirme broşürü

Page 1 of 3
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
VALSARTAN-MEDO 80 MG, VALSARTAN-MEDO 160 MG
Film-coated tablets
COMPOSITION:
Valsartan-Medo 80 mg
Film-Coated Tablets
Each film-coated tablet contains: Valsartan 80 mg
Valsartan-Medo 160 mg
Film-Coated Tablets
Each film-coated tablet contains: Valsartan 160 mg
INACTIVE AND ALLERGENIC INGREDIENTS: See section 6 “Further
Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise information about the medicine. If you
have further questions, refer to the
doctor or pharmacist.
This medicine has been prescribed for the treatment of your ailment.
Do not pass it on to others. It may harm them, even if it seems to you
that their ailment is similar.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
VALSARTAN-MEDO 80 MG AND VALSARTAN-MEDO 160 MG are intended for the
treatment of hypertension. For the treatment of heart failure and to
reduce hospitalizations in patients
with intolerance to angiotensin converting enzyme inhibitors (ACEi).
For treatment following myocardial infarction, to improve survival.
•
Hypertension increases the workload of the heart and arteries. If the
hypertension is not treated, damage to the blood vessels of the brain,
heart and kidneys could result.
The result may cause a stroke, heart failure or kidney failure.
Hypertension increases the risk of heart attacks. Lowering blood
pressure to normal levels reduces the risk of
developing these disorders.
•
For the treatment of adult patients following a heart attack
(myocardial infarction), in order to improve survival and reduce
additional heart problems.
•
For the treatment of symptomatic heart failure in adult patients.
Heart failure includes shortness of breath and swelling of the legs
and feet due to fluid buildup. Heart failure
means that the heart muscle cannot pump blood strongly enough to
supply all the blood needed by the body.
T